New Millennium Oral Care Inc.

DepEd's health initiative for schoolchildren bags international award.
Philippines News Agency; 12/20/2009; 1079 words; ...Essential Health Care Program (EHCP...primary health care among school children...successes; explore new avenues for collaboration...including the Millennium Development Goals...implemented in public day care and elementary...suffer from other oral health problems...Fit For School ...

VELCADE[R] Bortezomib for Injection to be Featured in Plenary Session at American Society of Hematology.(Conference notes)
Blood Weekly; 12/17/2009; 2150 words; Millennium: The Takeda...8, 2009 in New Orleans, Louisiana...abstracts include an oral presentation...Abstract #3 Oral Plenary session...Abstract #128 Oral presentation...Costs and Health Care Utilization Presenter...Analysis Group, Inc., Boston...

Reportlinker Adds Multiple Myeloma Therapeutics - US Market Trends & Analysis.
PR Newswire; 12/2/2009; 1654 words; NEW YORK, Dec. 2...offer palliative care such as, reduction...by BizAcumen, Inc. Our reports...Therapy: The New Norm of Future Treatment 7 New Generation Drugs...Takeda Acquires Millennium Pharmaceuticals...Approval for Revlimid Oral Cancer Drug 36...

Millennium Initiates Phase II Trial for Diffuse Large B-Cell Lymphoma.
Heart Disease Weekly; 11/8/2009; 1931 words; Millennium: The Takeda...lymphoma (see also Millennium: The Takeda...standard of care in this disease...Pharmaceuticals, Inc. and Johnson...therapy include new or worsening...failure, and new onset of decreased...Patients on oral antidiabetic...

News and FDA Updates for Omnicare (NYSE:OCR), BioClinica (NASDAQ:BIOC), Antares (NYSE:AIS), Teva (Nasdaq:TEVA).
M2 Presswire; 7/31/2009; 1024 words; ...Omnicare, Inc. (NYSE:OCR...pharmaceutical care for the elderly...BioClinica, Inc. (NASDAQ...EDT at the Millennium Broadway Hotel in New York City. On...Antares Pharma, Inc. (NYSE:AIS...subsequent written and oral forward-looking...